NCT04330664 2025-04-04Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)Mirati Therapeutics Inc.Phase 1 Completed86 enrolled
NCT04975256 2024-12-16Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)Mirati Therapeutics Inc.Phase 1 Terminated7 enrolled